- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Niraparib industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
TESARO
Everest Pharmaceuticals Limited
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
100mg*30 Capsules
100mg*60 Capsules
100mg*90 Capsules
Application:
Recurrent Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Niraparib Industry Overview
-
1.1.1 Niraparib Market Scope and Market Segments
-
1.1.2 Niraparib Industry Characteristics
-
1.1.3 Global and China Niraparib Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Niraparib Production Value and Growth Rate (2017-2028)
-
1.2 Global Niraparib Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 100mg*30 Capsules
-
1.2.2 100mg*60 Capsules
-
1.2.3 100mg*90 Capsules
-
1.3 Global Niraparib Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Recurrent Epithelial Ovarian Cancer
-
1.3.2 Fallopian Tube Cancer
-
1.3.3 Primary Peritoneal Cancer
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Niraparib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Niraparib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Niraparib Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Niraparib Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Niraparib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Niraparib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Niraparib Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Niraparib Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Niraparib Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Niraparib Industry Porter's Five Forces Model Analysis
-
2.2.3 Niraparib Industry PEST Analysis
-
2.3 Niraparib Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Niraparib Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Niraparib Industry
Chapter 3 Global and China Niraparib Market, by Manufacturer
-
3.1 Global and China Niraparib Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Niraparib Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Niraparib Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Niraparib Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Niraparib Market Top 3 Players
Chapter 4 Global and China Niraparib Market, by Type (2017-2028)
-
4.1 Niraparib Market Trend, by Type
-
4.2 Global Niraparib Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Niraparib Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Niraparib Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Niraparib Price Trend, by Type (2017-2028)
-
4.3 China Niraparib Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Niraparib Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Niraparib Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Niraparib Price Trend, by Type (2017-2028)
Chapter 5 Global and China Niraparib Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Niraparib Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Niraparib Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Niraparib Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Niraparib Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Niraparib Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Niraparib Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Niraparib Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Niraparib Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Niraparib Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Niraparib Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Niraparib Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Niraparib Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Niraparib Market Analysis
-
7.1 North America Niraparib Market, by Type
-
7.2 North America Niraparib Market, by Application
-
7.3 North America Niraparib Market Analysis and Forecast, by Country
-
7.3.1 United States Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Niraparib Market Analysis
-
8.1 Europe Niraparib Market, by Type
-
8.2 Europe Niraparib Market, by Application
-
8.3 Europe Niraparib Market Analysis and Forecast, by Country
-
8.3.1 Germany Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Niraparib Market Analysis
-
9.1 APAC Niraparib Market, by Type
-
9.2 APAC Niraparib Market, by Application
-
9.3 APAC Niraparib Market Analysis and Forecast, by Country
-
9.3.1 China Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Niraparib Market Analysis
-
10.1 Latin America, Middle East and Africa Niraparib Market, by Type
-
10.2 Latin America, Middle East and Africa Niraparib Market, by Application
-
10.3 Latin America, Middle East and Africa Niraparib Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Niraparib Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Niraparib Company Profiles
-
11.1 TESARO
-
11.1.1 TESARO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 TESARO Niraparib Product Profiles, Application and Specification
-
11.1.3 TESARO Niraparib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Everest Pharmaceuticals Limited
-
11.2.1 Everest Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Everest Pharmaceuticals Limited Niraparib Product Profiles, Application and Specification
-
11.2.3 Everest Pharmaceuticals Limited Niraparib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Niraparib Industry Investment Prospect and Risk Assessment
-
12.1 Niraparib Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Niraparib Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure China Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Global Niraparib Production Value and Growth Rate (2017-2028)
-
Figure China Niraparib Production Value and Growth Rate (2017-2028)
-
Figure Global Niraparib Market Size and Growth Rate of 100mg*30 Capsules (2017-2028)
-
Figure Global Niraparib Market Size and Growth Rate of 100mg*60 Capsules (2017-2028)
-
Figure Global Niraparib Market Size and Growth Rate of 100mg*90 Capsules (2017-2028)
-
Figure Global Niraparib Market Size and Growth Rate of Recurrent Epithelial Ovarian Cancer (2017-2028)
-
Figure Global Niraparib Market Size and Growth Rate of Fallopian Tube Cancer (2017-2028)
-
Figure Global Niraparib Market Size and Growth Rate of Primary Peritoneal Cancer (2017-2028)
-
Figure Global Niraparib Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Niraparib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Niraparib Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Niraparib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Niraparib Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Niraparib Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Niraparib Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Niraparib Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Niraparib Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Niraparib Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Niraparib Market Share, by Manufacturer in 2021
-
Figure Global and China Niraparib Market Share, by Manufacturer in 2022
-
Table Global Niraparib Sales Volume, by Type (2017-2028)
-
Table Global Niraparib Sales Volume Share, by Type (2017-2028)
-
Figure Global Niraparib Sales Volume Share, by Type (2017-2028)
-
Table Global Niraparib Sales Value, by Type (2017-2028)
-
Table Global Niraparib Sales Value Share, by Type (2017-2028)
-
Figure Global Niraparib Price Trend, by Type (2017-2028)
-
Table China Niraparib Sales Volume, by Type (2017-2028)
-
Table China Niraparib Sales Volume Share, by Type (2017-2028)
-
Figure China Niraparib Sales Volume Share, by Type (2017-2028)
-
Table China Niraparib Sales Value, by Type (2017-2028)
-
Table China Niraparib Sales Value Share, by Type (2017-2028)
-
Figure China Niraparib Price Trend, by Type (2017-2028)
-
Table Global Niraparib Sales Volume, by Application (2017-2028)
-
Table Global Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure Global Niraparib Sales Volume Share, by Application (2017-2028)
-
Table Global Niraparib Sales Value, by Application (2017-2028)
-
Table Global Niraparib Sales Value Share, by Application (2017-2028)
-
Figure Global Niraparib Sales Value Share, by Application (2017-2028)
-
Table China Niraparib Sales Volume, by Application (2017-2028)
-
Table China Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure China Niraparib Sales Volume Share, by Application (2017-2028)
-
Table China Niraparib Sales Value, by Application (2017-2028)
-
Table China Niraparib Sales Value Share, by Application (2017-2028)
-
Figure China Niraparib Sales Value Share, by Application (2017-2028)
-
Figure China Niraparib Production, Import, Consumption and Export (2017-2022)
-
Figure North America Niraparib Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Niraparib Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Niraparib Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Niraparib Production, Import, Consumption and Export (2017-2022)
-
Table North America Niraparib Sales Volume, by Type (2017-2028)
-
Table North America Niraparib Sales Volume Share, by Type (2017-2028)
-
Figure North America Niraparib Sales Volume Share, by Type (2017-2028)
-
Table North America Niraparib Sales Volume, by Application (2017-2028)
-
Table North America Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure North America Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure United States Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure United States Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Canada Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Niraparib Sales Value and Growth Rate (2017-2028)
-
Table Europe Niraparib Sales Volume, by Type (2017-2028)
-
Table Europe Niraparib Sales Volume Share, by Type (2017-2028)
-
Figure Europe Niraparib Sales Volume Share, by Type (2017-2028)
-
Table Europe Niraparib Sales Volume, by Application (2017-2028)
-
Table Europe Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure Europe Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure Germany Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure UK Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure UK Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure France Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure France Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Italy Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Spain Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Poland Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Russia Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Niraparib Sales Value and Growth Rate (2017-2028)
-
Table APAC Niraparib Sales Volume, by Type (2017-2028)
-
Table APAC Niraparib Sales Volume Share, by Type (2017-2028)
-
Figure APAC Niraparib Sales Volume Share, by Type (2017-2028)
-
Table APAC Niraparib Sales Volume, by Application (2017-2028)
-
Table APAC Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure APAC Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure China Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure China Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Japan Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure India Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure India Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Niraparib Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Niraparib Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Niraparib Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Niraparib Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Niraparib Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Niraparib Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Niraparib Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Niraparib Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Niraparib Sales Value and Growth Rate (2017-2028)
-
Table TESARO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table TESARO Product Profiles, Application and Specification
-
Table TESARO Niraparib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Everest Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Everest Pharmaceuticals Limited Product Profiles, Application and Specification
-
Table Everest Pharmaceuticals Limited Niraparib Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-

Chinese